186 related articles for article (PubMed ID: 19843348)
21. Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons.
Ikeda T; Abd El Galil KH; Tokunaga K; Maeda K; Sata T; Sakaguchi N; Heidmann T; Koito A
Nucleic Acids Res; 2011 Jul; 39(13):5538-54. PubMed ID: 21398638
[TBL] [Abstract][Full Text] [Related]
22. Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases.
Mahieux R; Suspène R; Delebecque F; Henry M; Schwartz O; Wain-Hobson S; Vartanian JP
J Gen Virol; 2005 Sep; 86(Pt 9):2489-2494. PubMed ID: 16099907
[TBL] [Abstract][Full Text] [Related]
23. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
[TBL] [Abstract][Full Text] [Related]
24. Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma.
Deng Y; Du Y; Zhang Q; Han X; Cao G
Cancer Lett; 2014 Feb; 343(2):161-71. PubMed ID: 24120759
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein B mRNA-editing, catalytic polypeptide cytidine deaminases and retroviral restriction.
Koito A; Ikeda T
Wiley Interdiscip Rev RNA; 2012; 3(4):529-41. PubMed ID: 22549984
[TBL] [Abstract][Full Text] [Related]
26. In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1).
Petersen-Mahrt SK; Neuberger MS
J Biol Chem; 2003 May; 278(22):19583-6. PubMed ID: 12697753
[TBL] [Abstract][Full Text] [Related]
27. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.
Bonvin M; Achermann F; Greeve I; Stroka D; Keogh A; Inderbitzin D; Candinas D; Sommer P; Wain-Hobson S; Vartanian JP; Greeve J
Hepatology; 2006 Jun; 43(6):1364-74. PubMed ID: 16729314
[TBL] [Abstract][Full Text] [Related]
28. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.
Ezzikouri S; Kitab B; Rebbani K; Marchio A; Wain-Hobson S; Dejean A; Vartanian JP; Pineau P; Benjelloun S
J Viral Hepat; 2013 Oct; 20(10):678-86. PubMed ID: 24010642
[TBL] [Abstract][Full Text] [Related]
29. Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma.
Xu R; Zhang X; Zhang W; Fang Y; Zheng S; Yu XF
Hepatology; 2007 Dec; 46(6):1810-20. PubMed ID: 17847074
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
[TBL] [Abstract][Full Text] [Related]
31. Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Luo X; Huang Y; Chen Y; Tu Z; Hu J; Tavis JE; Huang A; Hu Y
PLoS One; 2016; 11(6):e0157708. PubMed ID: 27310677
[TBL] [Abstract][Full Text] [Related]
32. APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice.
Turelli P; Liagre-Quazzola A; Mangeat B; Verp S; Jost S; Trono D
J Virol; 2008 Jul; 82(13):6585-90. PubMed ID: 18434399
[TBL] [Abstract][Full Text] [Related]
33. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.
Jost S; Turelli P; Mangeat B; Protzer U; Trono D
J Virol; 2007 Oct; 81(19):10588-96. PubMed ID: 17652382
[TBL] [Abstract][Full Text] [Related]
34. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases.
Koito A; Ikeda T
Front Microbiol; 2013; 4():28. PubMed ID: 23431045
[TBL] [Abstract][Full Text] [Related]
35. APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription.
Chen Y; Hu J; Cai X; Huang Y; Zhou X; Tu Z; Hu J; Tavis JE; Tang N; Huang A; Hu Y
Antiviral Res; 2018 Jan; 149():16-25. PubMed ID: 29129707
[TBL] [Abstract][Full Text] [Related]
36. Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression.
Zhang W; Zhang X; Tian C; Wang T; Sarkis PT; Fang Y; Zheng S; Yu XF; Xu R
Cell Microbiol; 2008 Jan; 10(1):112-21. PubMed ID: 17672864
[TBL] [Abstract][Full Text] [Related]
37. APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G.
Bouzidi MS; Caval V; Suspène R; Hallez C; Pineau P; Wain-Hobson S; Vartanian JP
J Mol Biol; 2016 Aug; 428(17):3514-28. PubMed ID: 27289067
[TBL] [Abstract][Full Text] [Related]
38. An overview of cytidine deaminases.
Navaratnam N; Sarwar R
Int J Hematol; 2006 Apr; 83(3):195-200. PubMed ID: 16720547
[TBL] [Abstract][Full Text] [Related]
39. Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses.
Rulli SJ; Mirro J; Hill SA; Lloyd P; Gorelick RJ; Coffin JM; Derse D; Rein A
J Virol; 2008 Jul; 82(13):6566-75. PubMed ID: 18448535
[TBL] [Abstract][Full Text] [Related]
40. Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G.
Chen KM; Harjes E; Gross PJ; Fahmy A; Lu Y; Shindo K; Harris RS; Matsuo H
Nature; 2008 Mar; 452(7183):116-9. PubMed ID: 18288108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
